![]() |
|
Anakinra
FDA approves Kineret (anakinra) for the treatment of NOMID |
Levonorgestrel
U.S. FDA Approves Bayer's Skyla (Levonorgestrel-Releasing Intrauterine System) 13.5 mg For Prevention Of Pregnancy For Up To Three Years |
|
Budesonide
Santarus Receives FDA Approval of Uceris (budesonide) for the Induction of Remission in Patients with Active, Mild to Moderate Ulcerative Colitis |
Influenza Vaccine, Recombinant Hemagglutinin
FDA Approves Flublok (influenza vaccine, recombinant hemagglutinin) - New Seasonal Influenza Vaccine Made Using Novel Technology |
|
Pooled Plasma (Human)
FDA Approves Octaplas (pooled plasma (human)) to Treat Patients with Blood Clotting Disorders |
Onabotulinumtoxina
FDA Approves Botox (onabotulinumtoxinA) to Treat Overactive Bladder |
|
Sumatriptan
NuPathe's Zecuity (sumatriptan) Approved by the FDA for the Acute Treatment of Migraine |
Deferasirox
FDA Approves Exjade (deferasirox) to Remove Excess Iron in Patients with Genetic Blood Disorder |
|
Imatinib
FDA Approves Gleevec (imatinib mesylate) for Children with Acute Lymphoblastic Leukemia |
Oxybutynin Hydrochloride
FDA Approves Over-the-Counter Oxytrol ((oxybutynin) Transdermal System ) for Women to treat Overactive Bladder |
|
Pneumococcal 13-Valent Conjugate Vaccine
Pfizer Receives FDA Approval For The Use Of Prevnar 13 (pneumococcal 13-valent conjugate vaccine)In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease |
Alogliptin
Takeda Receives FDA Approval for Nesina (alogliptin) for Type 2 Diabetes |
|
Alogliptin And Pioglitazone
Takeda Receives FDA Approval for Oseni (alogliptin and pioglitazone) for Type 2 Diabetes |
Alogliptin And Metformin
Takeda Receives FDA Approval for Kazano (alogliptin and metformin) for Type 2 Diabetes |
|
Mipomersen Injection
FDA Approves New Orphan Drug Kynamro (mipomersen) to Treat Inherited Cholesterol Disorder |